Figure 1: R&D Antibody array showing the effects of Trop2 loss on EGFR, Her2, c-MET, and IGF-1R activity. No measureable increase in the activity of these proteins upon Trop2 loss was observed in this assay.
Figure 3: Trop2 expression inversely correlates with ErB3 activation (p-ErbB3 staining).
Additional representative cases of primary tumors with high and low Trop2 expression are shown with the corresponding levels of p-ErbB3, ErbB3, and E-cadherin. Panels A-D and E-H are adjacent sections of Trop2 high and low tumors respectively. ErbB3 expression is readily apparent in Trop2 high cases despite the absence of p-ErbB3 staining in these tumors. Images are photographed at 20x power. These were used to determine the Trop2 domains required to interact with NRG1 and needed to suppress ErbB3 activation. Shown are the full length Flag-epitope tagged Trop2, and Trop2 deletion mutants that lack either the EGF-like domain or the thyroglobulin type-1 domain, both of which are found in the extracellular region of Trop2. B. SCC1 cells (stably harboring shLacZ or shTrop2 lentiviral plasmids) were harvested twenty-four hours after being transiently transfected with an empty pcDNA3.1 vector or the specified cDNA inserts. Protein lysates from these cells were used for NRG1 immunoprecipitation (NRG1 IP) and assessment of ErbB3 activation (input). Representative immunoblots of NRG1 immunoprecipitation with anti-mouse NRG1 followed by immunoblotting using anti-Flag antibody or anti-rabbit NRG1 reveal that only the full-length Trop2 cDNA interacts with NRG1. Immunoblots performed on input lysates show that only the full-length Trop2 cDNA can suppress ErbB3 activity. Quantification shows normalization of p-ErbB3 to total ErbB3. The Flag antibody identifies the faster migrating Trop2 deletion mutants. The anti-Trop2 antibody was raised against and recognizes epitopes in the wild-type extracellular domain and is less reactive with the deletion mutants.
